CD44 and cancer: CD44 has been shown to be a useful tumor marker for disease progression and metastasis in certain types of cancers, and our laboratory, as well as others, has shown that CD44 is not usually expressed in the normal ovary although it is expressed in 40-60% of primary ovarian tumors [2–5].